Walleye Trading’s Terns Pharmaceuticals TERN Stock Holding History

Walleye Trading’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.42M	Buy	+27,000	New	+$1.11M	﹤0.01%	1919

Other funds holding TERN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Walleye Trading's TERN Position: Q3 2024 in Review

Walleye Trading sold out of Terns Pharmaceuticals (TERN) in Q3 2024, closing a stake of 15,000 shares — an estimated $102K sold.

Walleye Trading first reported a position in TERN in Q1 2024 and held it in 2 quarters. The position peaked at $102K in Q2 2024. 156 funds tracked by Wall St. Rank hold TERN as of Q3 2024.

Walleye Trading reported no remaining Terns Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
Walleye Trading sold 15,000 Terns Pharmaceuticals shares in Q3 2024, an estimated $102K.
Walleye Trading first reported a position in Terns Pharmaceuticals in Q1 2024 and held it in 2 quarters.
Walleye Trading's Terns Pharmaceuticals position peaked at $102K in Q2 2024.
156 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q3 2024.

Based on Walleye Trading's 13F filing for Q3 2024, filed 14 Nov 2024.